Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7

Get the latest international news and world events from around the world.

Log in for authorized contributors

Astronomers spot an extremely rare galaxy mega-merger

Scale in the universe is hard to understand from a purely human perspective. Many times, the math just doesn’t sit well with our brains, which evolved to capture and process data about the world around us rather than grok the complexities of stellar dynamics and galaxy mergers. But every once in a while, astronomers find something that, if we can wrap our heads around the numbers, gives a sense of just how big the universe is.

That is precisely what a new paper, available on the arXiv preprint server from a group of astronomers led by Z.L. Wen of the Chinese Academy of Sciences, hopes to do when it describes a merger of not one, not two, but six supermassive galaxies and the active dynamics they are subject to.

Admittedly, this paper isn’t the one that originally found the cluster. That was done back in 2018 by several all-sky surveys, including the Two Micron All Sky Survey, WISE and SuperCOSMOS. But it was the first to identify that the cluster contained a group of six merging galaxies at its heart. That tidbit was hidden away in Dark Energy Spectroscopic Instrument (DESI) Legacy Imaging Surveys data.

Scientists Find a More Precise Way to Grow Artificial Blood Vessels, Using Magnets

Science may one day give us a way to replace damaged and diseased parts of the body with artificial replacements – but reproducing organs and tissues in the lab isn’t easy.

That’s especially true for networks of blood vessels, which at the level of fine, thread-like capillaries are microscopic – these capillaries can be as small as 0.005 millimeters (34 times thinner than a human hair), and only let blood cells through in single file.

Researchers led by a team from MIT have now published a study in PNAS that details a way of engineering blood vessels in the lab with significantly greater precision than before.

Study tests chronotype’s liver link and finds no significant association

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 medication-naïve adults with overweight or obesity. The exploratory findings cannot exclude smaller effects, particularly for fibrosis, and require confirmation in larger longitudinal studies.

How the most widespread parasite on Earth reads its genome

A parasite carried by billions of people worldwide often causes harmful infections during pregnancy and in immunocompromised individuals and is a leading infectious cause of blindness in South America. Once it enters the body, it can rapidly multiply, spreading from one cell to the next.

This single-celled organism, Toxoplasma gondii, belongs to the same group of microbes as the parasite that causes malaria and many other parasites of humans and animals. Cats are Toxoplasma’s main host, but it can infect most warm-blooded mammals, including humans, who typically become infected through contact with cat feces or by consuming undercooked meat or contaminated produce.

The parasite’s ability to survive and spread inside a host depends on its capacity to precisely control which proteins it makes and when. Proteins are the molecular machinery that carries out all of the parasite’s functions, from invading and manipulating host cells to making new copies of the pathogen that spread to other cells and hosts.

Mysterious ‘little red dots’ at the beginning time may finally have an explanation, thanks to newfound ’little blue companions‘

Astronomers may have found an unexpected origin for the mysterious “little red dots” that appear to be so common in James Webb Space Telescope surveys of the early universe.

Acid-resistant nanocage shows promise for targeted gastric cancer therapy

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transport therapeutic enzymes through the stomach’s acidic environment and activate a cancer-killing reaction at tumor sites. Early preclinical findings suggest that the approach may offer a new strategy for treating gastric cancer more precisely while reducing damage to healthy tissue.

The preclinical study, published in the Journal of Nanobiotechnology, was led by associate professor Chester Lee Drum, Department of Medicine and the Cardiovascular-Metabolic Disease Translational Research Program (TRP), NUS Medicine, together with co-first authors Dr. Muthu Kumaraswamy Shanmugam and Dr. Girish Vallerinteavide Mavelli, both senior research fellows at the Department of Medicine, NUS Medicine.

/* */